The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Leveraging Commercial Data Infrastructure in Clinical Drug Development is the greatest connectivity we can have in the ...

Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...

Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

The FDA will begin replacing animal testing in the development of monoclonal antibody therapies and other drugs with ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...